Stockreport

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript [Seeking Alpha]

Minerva Neurosciences, Inc  (NERV) 
Last minerva neurosciences, inc earnings: 3/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.minervaneurosciences.com/investor-relations
PDF Company Participants Rémy Luthringer - Executive Chairman & CEO Conference Call Participants Gregory Strauss Brian W. Kirkpatrick Corey Davis - Lifesci Adviso [Read more]